-
-
-
-
-
-
-
CorMedix (CRMD) PT Lowered to $15 at Leerink Partners
-
-
-
-
-
-
-
CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025
-
-
-
-
-
-
-
CorMedix to acquire Melinta Therapeutics for $300 million
-
-
-
-
-
-
-
CorMedix (CRMD) Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance
-
-
-
-
-
-
-
CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update
-
-
-
-
-
-
-
CorMedix (CRMD) Receives FDA Feedback on Potential Label Expansion
-
-
-
-
-
-
-
CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

